Articles

The committee consists of the seven Elected Officers of the Organization, the immediate Past Chair of the Organization, the Vice Chairs of each Section's Governing Board, and At-Large Directors selected from the Full Board by the Chair and approved by the Board. The committee is authorized to exercise all powers of the Full Board, except for certain powers reserved for the Full Board under BIO's Bylaws.
Staff Contact: Tom DiLenge

BIO Staff Contact: Hans Sauer, Deputy General Counsel, IP
Committee Chair: Kenneth Dow, Johnson & Johnson
Past Chair: Tom Kelley, Monsanto
 
Existing Subcommittees and Working Groups:
  Amicus Subcommittee - Chair: Brian Barrett, Patent Counsel, Eli Lilly & Company

What is your opinion of biotechnology companies – very favorable, somewhat favorable, somewhat unfavorable, or very unfavorable?

Executive Summary

This paper demonstrates that the federal Renewable Fuel Standard (―RFS‖)—established under the Energy Policy Act of 2005, enhanced pursuant to the Energy Independence and Security Actof 2007 (―EISA‖), and enforced by the Environmental Protection Agency (―EPA‖)— provides considerable market motivation to drive investment in cellulosic and advanced biofuels.

As the use of agricultural biotechnology increases globally, people need information about food production that is truthful, so they can form opinions based on facts, not fear.

Currently, synthetic rubber is derived entirely from petrochemical sources. Genencor®, a Division of Danisco U.S. Inc., together with The Goodyear Tire & Rubber Company, is currently working on the development of a fermentation-based process for the BioIsoprene™ monomer.  

Synthetic biology is a new interdisciplinary area that involves the application of engineering principles to biology.

Advertising opportunities with BIO.

Department: Business Development

Reports to: Manager, Business Development

Primary Purpose of the Position:

The primary purpose of this position is to provide analytic and web support to the Business Development Department primarily through the integration of marketing and information into overall business development strategy.

BIO represents more than 1,200 companies and organizations in Washington, DC, state capitals and international fora.

BIO membership is company based;  BIO does not offer individual memberships.

Online Membership Application Form

Membership Application Form to Print & Fax (PDF)

2013 Dues Schedule (PDF)

Is my organization eligible for membership? Where can I find an application to join BIO? Does BIO offer membership to non-biotech companies?

Members.BIO.org
BIO's members-only Web site is a platform for member services. Any employee of a member company can access the site.
Log-in now to Members.BIO.org

How do I become a member? How much does membership in BIO cost? How long does membership last? Does BIO offer membership to non-biotech companies?

A strong Network will bolster public awareness of the industry and encourage more investment dollars.

Interested?

We offer a competitive, employer-paid benefits package. Send resume, cover letter, and salary requirements to:

Biotechnology Industry Organization
Human Resources Department
1201 Maryland Avenue, SW
Suite 900
Washington, DC 20024
Phone: 202.962.9200
Fax: 202.488.6308
Email: hr@bio.org

To help better inform and educate consumers - we have gathered important findings from across the scientific community about biotechnology and food safety.

Society has tapped just a small fraction of the many potential uses and benefits of biotechnology.

As budget talks aimed at raising the federal debt ceiling move to the presidential level this week, CNBC came to the 2011 BIO International Convention to interview BIO President and CEO Jim Greenwood about the role biotech can play in lowering the U.S. budget deficit.

Biofuels Digest and BIO have launched the Summer 2011 Bioenergy Business Outlook Survey.

The U.S. Supreme Court issued a favorable decision in the critical case of Microsoft v. i4i, in which Microsoft challenged the “clear and convincing evidence” standard traditionally used by courts in determining whether to invalidate an issued U.S. patent.